CAMP and neuroblastoma: In contrast, the expression of the CAMP gene and levels of LL-37 secretion are significantly decreased in gastric and colorectal cancers, oral squamous cell carcinoma, leukemia, lymphoma and SH-SY5Y neuroblastoma cells [25].